Sense receives CE marking for Veros Covid-19 instrument-free molecular test
Sense anticipates launching Veros Covid-19 in Europe this quarter, initially in Ireland, Benelux and the Nordic regions
Sense anticipates launching Veros Covid-19 in Europe this quarter, initially in Ireland, Benelux and the Nordic regions
Novel technology combines ACUVUE daily disposable contact lenses with an established antihistamine in FDA- first in its new category
It is the first approved blood test that can predict likely progression to Alzheimer's Disease up to six years in advance
It is a Phase 3 ready anti-myostatin adnectin for Spinal Muscular Atrophy (SMA).
Alchemee's flagship brand Proactiv@ is an iconic product synonymous with acne care
New inhalers would have near-zero Global Warming Potential propellant
The agreement also had a permanent safeguard mechanism which can be resorted to in a situation of sudden surge in imports.
Darolutamide is developed jointly by Bayer and Orion Corporation
Ligand expects 2022 royalties of $55 million to $60 million, material sales of $40 million to $50 million, and contract revenue of $52 million to $62 million.
Moderna's vaccine has already received regulatory approval for adults and adolescents in Australia
Subscribe To Our Newsletter & Stay Updated